1 Department of Diabetes, Endocrinology and Nutrition, Hospital de Sant Pau (HSP) , Universitat Autònoma de Barcelona (UAB), Barcelona, Spain .
2 MK Diabetes Clinic , Ghaziabad, India .
Metab Syndr Relat Disord. 2017 Dec;15(10):494-499. doi: 10.1089/met.2017.0103. Epub 2017 Oct 17.
We undertook a study to assess β-cell function, metabolic and immunological features of patients with latent autoimmune diabetes in adults (LADA) and investigate heterogeneity within LADA based on low and high glutamic acid decarboxylase autoantibodies (GADA) titers.
A total of 139 patients with adult-onset diabetes were examined cross-sectionally in the National capital region of Northern India. Medical history of all subjects was reviewed with the aim of collecting clinical data. Glucose, glycosylated hemoglobin, lipid profile, creatinine, C-peptide, and GADA were measured in 10-12 hrs fasting blood sample.
Assessment of metabolic features revealed lower mean systolic blood pressure in subjects with LADA than in those with type 2 diabetes (DM2). Mean triglyceride levels were lower in LADA subjects compared to DM2 subjects. Compared to DM2 subjects, prevalence of metabolic syndrome (MS) was also lower in LADA subjects. Compared to GADA-low, all GADA-high patients were male, had lower waist circumference, fasting C-peptide (FCP), and prevalence of MS. Compared to DM2 patients, GADA-high patients were younger, had lower age at onset, body mass index, waist circumference, systolic blood pressure, triglycerides, FCP, and prevalence of MS. The rate of patients on insulin was higher in GADA-high compared to DM2. There were no significant differences between characteristics of DM2 and GADA-low patients.
Our results indicate that LADA patients have distinct metabolic features with lower residual β-cell function than DM2 patients. GADA titer is important parameter in defining the severity of the disease as patients with high GADA titer tend to have significant β-cell impairment.
我们进行了一项研究,评估了成人隐匿性自身免疫性糖尿病(LADA)患者的β细胞功能、代谢和免疫学特征,并根据谷氨酸脱羧酶自身抗体(GADA)滴度的高低,探讨了 LADA 内部的异质性。
在印度北部首都地区,我们对 139 名成年发病的糖尿病患者进行了横断面研究。回顾了所有患者的病史,旨在收集临床数据。在禁食 10-12 小时后,测量了血糖、糖化血红蛋白、血脂谱、肌酐、C 肽和 GADA。
代谢特征评估显示,与 2 型糖尿病(DM2)患者相比,LADA 患者的平均收缩压较低。与 DM2 患者相比,LADA 患者的平均甘油三酯水平较低。与 DM2 患者相比,LADA 患者的代谢综合征(MS)患病率也较低。与 GADA 低相比,所有 GADA 高患者均为男性,腰围、空腹 C 肽(FCP)和 MS 患病率较低。与 DM2 患者相比,GADA 高患者年龄较小,发病年龄、体重指数、腰围、收缩压、甘油三酯、FCP 和 MS 患病率较低。与 DM2 患者相比,GADA 高患者的胰岛素使用率较高。DM2 和 GADA 低患者的特征无显著差异。
我们的结果表明,LADA 患者具有独特的代谢特征,其残余β细胞功能低于 DM2 患者。GADA 滴度是定义疾病严重程度的重要参数,因为高 GADA 滴度的患者往往存在明显的β细胞损伤。